
Nordson Corporation company profile
$322.87+0.09%Close 17 Nov 2026 · Market value $17.87B
About Nordson Corporation
Nordson Corporation engineers, manufactures and markets precision dispensing, applying, controlling, testing, inspecting and surface-treatment equipment and systems. Its products dispense and control adhesives, coatings, polymers, sealants, biomaterials and other fluids, and include medical components such as catheters, cannulas, medical balloons and medical tubing. The company operates through segments serving consumer non-durable, consumer durable and technology end markets, including packaging, electronics, medical, appliances, energy, transportation, precision agriculture and building and construction. It sells primarily through a direct sales force and distributors, with direct operations in more than 35 countries. Headquartered in Westlake, Ohio, it has manufacturing facilities in the United States and several other countries, and about 67 percent of its 2025 revenues were generated outside the United States.
A summary of the business section of the company's latest annual report, filed 17 Dec 2025.
Company facts
| Ticker | NDSN · Nasdaq |
|---|
| Sector | Industrials |
|---|
| Industry | Industrial Machinery & Supplies & Components |
|---|
| Index | S&P 500 |
|---|
| Fiscal year ends | 31 October |
|---|
| Reporting currency | USD |
|---|
| CIK | 72331 |
|---|
| Latest annual report | 10-K, filed 17 Dec 2025 |
|---|
Officers and directors
| Name | Role | Shares owned | Latest Form 4 |
|---|
| Sundaram Nagarajan | Director, President and Chief Executive Officer | 190K · < 1% | Open-market sale, 24 Feb 2026 |
|---|
| Joseph Kelley | Executive Vice President | 52.5K · < 1% | Shares withheld for tax, 31 Oct 2026 |
|---|
| Stephen Lovass | Former Executive Vice President | 29.1K · < 1% | Shares withheld for tax, 13 Jun 2025 |
|---|
| Michael Merriman, Jr. | Director | 28.7K · < 1% | Grant or award, 1 Nov 2026 |
|---|
| Srinivas Subramanian | Executive Vice President | 20.7K · < 1% | Shares withheld for tax, 31 Oct 2026 |
|---|
| Victor Richey, Jr. | Chair of the Board | 20.1K · < 1% | Grant or award, 1 Nov 2026 |
|---|
| Frank Jaehnert | Director | 19.5K · < 1% | Grant or award, 1 Nov 2026 |
|---|
| Jennifer McDonough | Executive Vice President, General Counsel and Secretary | 13.3K · < 1% | Open-market sale, 27 Aug 2026 |
|---|
| Ginger Jones | Director | 5.5K · < 1% | Grant or award, 1 Nov 2026 |
|---|
| John DeFord | Director | 4.8K · < 1% | Grant or award, 1 Nov 2026 |
|---|
| Daniel Hopgood | Executive Vice President and Chief Financial Officer | 3.6K · < 1% | Option exercise, 26 Aug 2026 |
|---|
| Jennifer Parmentier | Director | 3.5K · < 1% | Grant or award, 1 Nov 2026 |
|---|
| Milton Morris | Director | 2.1K · < 1% | Grant or award, 1 Nov 2026 |
|---|
| Christopher. Mapes | Director | 2.0K · < 1% | Grant or award, 1 Nov 2026 |
|---|
| Annette Clayton | Director | 1.8K · < 1% | Grant or award, 1 May 2026 |
|---|
| Rutledge Joseph M | VP, CAO | — | Open-market sale, 15 Sep 2026 |
|---|
| Hall Justin E | EVP | — | Shares withheld for tax, 1 Sep 2026 |
|---|
| DeVries James E | Executive Vice President | — | Shares withheld for tax, 16 Apr 2026 |
|---|
| Siddiqui Sarah | EVP, CHRO | — | Shares withheld for tax, 27 Feb 2026 |
|---|
| Shamrock Stephen F | VP and CAO | — | Code J, 10 Jul 2025 |
|---|
Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.
NDSN in the terminal
The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.